14 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler
RxNorm concept 746810, clinical drug (scd). Prescribable name: mometasone furoate 220 MCG/INHAL Dry Powder Inhaler, 14 ACTUAT.
- RxCUI
- 746810
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/746810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
mometasone furoate 220 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT
Related concepts
- mometasone furoate 0.22 MG/ACTUAT (SCDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- 14 ACTUAT mometasone furoate 0.22 MG/ACTUAT Dry Powder Inhaler [Asmanex] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 746810 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/746810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 746810. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.